Merz Americas’ CEO Bob Rhatigan Discusses Reclaimers, Toxin Commoditization, and Christie Brinkley

Summary: In this Aesthetics Innovators Podcast episode, Bob Rhatigan, CEO of Merz Americas, talks with co-host Grant Stevens, MD, about the battle building in the toxin market, including Merz’s own Xeomin. Is the risk of commoditization real? Rhatigan also...